Send the following on WhatsApp
Continue to Chat高端新冠疫苗二期解盲成功!血清抗體轉換率為 99.8%,安全性高 https://geneonline.news/taiwan-covid-19-vaccine-phase-2/?variant=zh-cn
高端新冠疫苗二期解盲成功!血清抗體轉換率為 99.8%,安全性高 https://geneonline.news/taiwan-covid-19-vaccine-phase-2/?variant=zh-cn